N.J. called hot spot for Candida auris

The CDC says most cases of Candida auris in the United States are in New York City, Chicago and New Jersey


The Centers for Disease Control and Prevention (CDC) saya New Jersey is one of the hot spots for Candida auris, according to an article on the CBS Philly website.

The CDC says most of Candida auris in the United States are in New York City, Chicago and New Jersey, where there are 124 confirmed cases along with 22 probable cases.

There have been 715 confirmed or suspected cases of the rare fungus in the United States.

Experts say hospital infection control is a critical part of preventing the infection.

Read the article.



August 12, 2019


Topic Area: Infection Control


Recent Posts

Wider View: Planning LED Upgrades Across a Healthcare Portfolio

Upgrade planning has to start with a systemwide, portfolio approach rather than a site-by-site mindset.


Cone Health Plans Hospital in Forsyth County of North Carolina

The 198,593 square-foot facility will be in southeast Forsyth County.


Carvel Autism Health to Open New Therapy Clinic in Altoona, Iowa

The clinic features colorful, sensory-friendly spaces where children work one-on-one with therapists.


Cleanliness in Hospitals: Clinical Priority and Community Perception

EVS managers and communities value cleanliness for complementary reasons: managers for safety and compliance, communities for trust and comfort.


Dana-Farber Receives $50M Gift for Planned Cancer Hospital

A $50 million grant from the Yawkey Foundation will support construction of Dana-Farber Cancer Institute’s planned 450,000-square-foot cancer hospital.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.